GlassScriptPhysician profile
Robert Wh Mason
NPI 1124077359
$3,689.19
in general payments reported to CMS, 2019-2025
16 companies · $487 in 2025
The $487 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $76.47 · 2021: $71.98 · 2022: $206 · 2023: $2,519 · 2024: $188 · 2025: $487.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,024 · Food and Beverage: $1,168.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,024.49 |
| Food and Beverage | $1,168.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $2,024.49 | 2023 | Clarus |
| Genentech USA, INC. | $428.64 | 2019-2025 | Vabysmo |
| Abbvie INC. | $292.65 | 2022-2025 | |
| Alcon Vision LLC | $253.59 | 2022-2023 | Clareon |
| Bausch & Lomb Americas INC. | $195.25 | 2023-2025 | Xipere, Stellaris, Visudyne |
| Johnson & Johnson Vision Care, INC. | $110.53 | 2025 | |
| Allergan, INC. | $85.96 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $71.98 | 2022-2025 | Syfovre |
| Eyepoint US, INC. | $50.27 | 2023 | |
| Alimera Sciences, INC. | $42.94 | 2021-2023 | Iluvien |
| Oyster Point Pharma, INC. | $33.90 | 2023 | Tyrvaya |
| Regeneron Healthcare Solutions, INC. | $32.34 | 2023 | Eylea Hd |
| Ani Pharmaceuticals, INC. | $23.50 | 2025 | Iluvien |
| Astellas Pharma US INC | $17.87 | 2025 | Izervay |
| Vyera Pharmaceuticals, LLC | $13.76 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.